Comparative diagnostic accuracy and clinical utility of the Mini-Addenbrooke's Cognitive Examination, ACE-III, and MMSE for functional staging across the Alzheimer's disease continuum.
INTRODUCTION The advent of disease-modifying therapies has heightened the demand for cognitive screening instruments capable of detecting cognitive impairment and supporting both functional staging and longitudinal monitoring of Alzheimer's disease (AD). Although the Addenbrooke's Cognitive Examination III (ACE-III) of...